ATE169497T1 - Verfahren zur herstellung von mikrogranulaten, die nach umhüllung zur suspendierung in flüssigen pharmazeutika geeignet sind - Google Patents

Verfahren zur herstellung von mikrogranulaten, die nach umhüllung zur suspendierung in flüssigen pharmazeutika geeignet sind

Info

Publication number
ATE169497T1
ATE169497T1 AT94101105T AT94101105T ATE169497T1 AT E169497 T1 ATE169497 T1 AT E169497T1 AT 94101105 T AT94101105 T AT 94101105T AT 94101105 T AT94101105 T AT 94101105T AT E169497 T1 ATE169497 T1 AT E169497T1
Authority
AT
Austria
Prior art keywords
coating
microgranules
pharmaceutics
suspension
liquid
Prior art date
Application number
AT94101105T
Other languages
English (en)
Inventor
Giancarlo Santus
Giuseppe Bottoni
Roberto Golzi
Original Assignee
Recordati Chem Pharm
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=11364782&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE169497(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Recordati Chem Pharm filed Critical Recordati Chem Pharm
Application granted granted Critical
Publication of ATE169497T1 publication Critical patent/ATE169497T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Glanulating (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
AT94101105T 1993-01-28 1994-01-26 Verfahren zur herstellung von mikrogranulaten, die nach umhüllung zur suspendierung in flüssigen pharmazeutika geeignet sind ATE169497T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITMI930136A IT1264020B (it) 1993-01-28 1993-01-28 Procedimento per la preparazione di microgranuli idonei alla sospensione in liquidi

Publications (1)

Publication Number Publication Date
ATE169497T1 true ATE169497T1 (de) 1998-08-15

Family

ID=11364782

Family Applications (1)

Application Number Title Priority Date Filing Date
AT94101105T ATE169497T1 (de) 1993-01-28 1994-01-26 Verfahren zur herstellung von mikrogranulaten, die nach umhüllung zur suspendierung in flüssigen pharmazeutika geeignet sind

Country Status (9)

Country Link
US (1) US5460828A (de)
EP (1) EP0608850B1 (de)
JP (1) JP3184912B2 (de)
AT (1) ATE169497T1 (de)
DE (1) DE69412295T2 (de)
DK (1) DK0608850T3 (de)
ES (1) ES2122050T3 (de)
IT (1) IT1264020B (de)
SG (1) SG47772A1 (de)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5958458A (en) * 1994-06-15 1999-09-28 Dumex-Alpharma A/S Pharmaceutical multiple unit particulate formulation in the form of coated cores
IT1270594B (it) * 1994-07-07 1997-05-07 Recordati Chem Pharm Composizione farmaceutica a rilascio controllato di moguisteina in sospensione liquida
GB9518465D0 (en) * 1995-09-09 1995-11-08 Smithkline Beecham Seiyaku Kk Pharmaceuticals
US6214386B1 (en) 1995-11-22 2001-04-10 Recordati, S.A. Prompt-release oral pharmaceutical compositions for extemporaneous suspensions
GB9710767D0 (en) * 1996-06-26 1997-07-23 On Ninh Analgesic and anti-inflamatory compositions comprising domperidone and methods of using same
FR2758459B1 (fr) * 1997-01-17 1999-05-07 Pharma Pass Composition pharmaceutique de fenofibrate presentant une biodisponibilite elevee et son procede de preparation
US6184220B1 (en) * 1998-03-27 2001-02-06 Boehringer Ingelheim Pharma Kg Oral suspension of pharmaceutical substance
GB9816899D0 (en) 1998-08-05 1998-09-30 Boots Co Plc Therapeutic agents
JP2000128774A (ja) 1998-10-26 2000-05-09 Tanabe Seiyaku Co Ltd 薬物を含有する球形微粒子の製法
WO2000044240A1 (en) * 1999-01-29 2000-08-03 Meri Charmyne Russell Treatement of colic and gut spasm in horses and other vertebrates
US10179130B2 (en) 1999-10-29 2019-01-15 Purdue Pharma L.P. Controlled release hydrocodone formulations
JP4806507B2 (ja) 1999-10-29 2011-11-02 ユーロ−セルティーク エス．エイ． 制御放出ヒドロコドン処方
US6730691B1 (en) 2000-02-10 2004-05-04 Miles A. Galin Uses of alpha adrenergic blocking agents
CN101653411A (zh) 2000-10-30 2010-02-24 欧罗赛铁克股份有限公司 控释氢可酮制剂
US20020119196A1 (en) * 2000-12-21 2002-08-29 Narendra Parikh Texture masked particles containing an active ingredient
JP4848101B2 (ja) * 2001-08-17 2011-12-28 株式会社フジモト・コーポレーション 徐放性マイクロペレット
US6723348B2 (en) * 2001-11-16 2004-04-20 Ethypharm Orodispersible tablets containing fexofenadine
IL164152A0 (en) * 2002-03-26 2005-12-18 Teva Pharma Drug microparticles
US20040131771A1 (en) * 2002-11-04 2004-07-08 Poul Egon Bertelsen Coating of particulate material with organic based coating composition for the preparation of drug delivery systems
US8062664B2 (en) * 2003-11-12 2011-11-22 Abbott Laboratories Process for preparing formulations of lipid-regulating drugs
US20050131079A1 (en) * 2003-12-10 2005-06-16 Pujara Chetan P. Cefdinir oral suspension
EP1568369A1 (de) 2004-02-23 2005-08-31 Boehringer Ingelheim Vetmedica Gmbh Verwendung von Meloxicam zur Behandlung von Atemwegserkrankungen bei Schweinen
AR045841A1 (es) * 2004-09-28 2005-11-16 Richmond Sa Com Ind Y Financie Una composicion farmaceutica solida que comprende al tiazolil metil ester del acido [5s-(5r*, 8r*, 10r*,11r*)] -10- hidroxi-2- metil-5-(1-metiletil)-1-[2-(1-metiletil)-4-tiazolil]-3,6-dioxo-8,11-bis(fenilmetil)-2,4,7,12- tetraazatridecan-13-oico y un procedimiento para prepararla.
US20080069891A1 (en) 2006-09-15 2008-03-20 Cima Labs, Inc. Abuse resistant drug formulation
US8445018B2 (en) 2006-09-15 2013-05-21 Cima Labs Inc. Abuse resistant drug formulation
CN101668513A (zh) * 2007-02-23 2010-03-10 格拉特气体技术公司 确定待施用的包衣的重量以形成控释剂型的方法
US8445545B2 (en) * 2008-05-07 2013-05-21 Nicholas DeSica Pharmaceutical composition, method of preparation and methods of treating aches/pains
WO2011143120A1 (en) 2010-05-11 2011-11-17 Cima Labs Inc. Alcoholres i stant metoprolol - containing extended - release oral dosage forms
US9962336B2 (en) * 2014-05-01 2018-05-08 Sun Pharmaceutical Industries Limited Extended release suspension compositions
US20180104197A9 (en) 2014-05-01 2018-04-19 Sun Pharmaceutical Industries Limited Extended release liquid compositions of metformin
AU2015294912A1 (en) 2014-07-30 2017-02-16 Sun Pharmaceutical Industries Limited Dual-chamber pack
US10258583B2 (en) 2014-05-01 2019-04-16 Sun Pharmaceutical Industries Limited Extended release liquid compositions of guanfacine
PL3137060T5 (pl) 2014-05-01 2024-04-08 Sun Pharmaceutical Industries Ltd Kompozycje zawiesinowe o przedłużonym uwalnianiu
CA2959414C (en) * 2014-09-05 2023-03-14 Symbiomix Therapeutics, Llc Secnidazole for use in the treatment of bacterial vaginosis
US10369078B2 (en) 2016-05-02 2019-08-06 Sun Pharmaceutical Industries Limited Dual-chamber pack for pharmaceutical compositions
US10238803B2 (en) 2016-05-02 2019-03-26 Sun Pharmaceutical Industries Limited Drug delivery device for pharmaceutical compositions

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5854852B2 (ja) * 1975-03-17 1983-12-07 武田薬品工業株式会社 サイリユウザイノセイゾウホウ
CA1114683A (en) * 1978-01-03 1981-12-22 Robert J. Boyle Fire retardant treatment of fire unstable materials and products
GB8628359D0 (en) * 1986-11-27 1986-12-31 Zyma Sa Galenical formulation
JPS63240934A (ja) * 1987-03-28 1988-10-06 Taisho Pharmaceut Co Ltd 薬物の造粒法
NL193682C (nl) * 1987-05-14 2000-07-04 Glaxo Group Ltd Beklede cefuroximaxetilsamenstelling.
IT1215726B (it) * 1988-01-18 1990-02-22 Alfa Wassermann Spa Formulazioni galeniche a cessione programmata.
US5296236A (en) * 1988-09-16 1994-03-22 Recordati S.A., Chemical And Pharmaceutical Company Controlled release therapeutic system for a liquid pharmaceutical formulations
CA1331713C (en) * 1988-12-29 1994-08-30 Hitoshi Iijima Granular composition for ruminant

Also Published As

Publication number Publication date
DK0608850T3 (da) 1999-05-17
ITMI930136A1 (it) 1994-07-28
US5460828A (en) 1995-10-24
EP0608850B1 (de) 1998-08-12
DE69412295D1 (de) 1998-09-17
DE69412295T2 (de) 1999-02-11
SG47772A1 (en) 1998-04-17
JP3184912B2 (ja) 2001-07-09
ITMI930136A0 (it) 1993-01-28
IT1264020B (it) 1996-09-09
ES2122050T3 (es) 1998-12-16
EP0608850A1 (de) 1994-08-03
JPH06319786A (ja) 1994-11-22

Similar Documents

Publication Publication Date Title
ATE169497T1 (de) Verfahren zur herstellung von mikrogranulaten, die nach umhüllung zur suspendierung in flüssigen pharmazeutika geeignet sind
DE68916048D1 (de) Verfahren zur Herstellung von monodispersen Polymerteilchen mit erhöhter Teilchengrösse.
DE69132504D1 (de) Verfahren zur Herstellung von hochreinem Titan und von einem Zerstäubungstarget
DE69718320D1 (de) Verfahren zur raschen herstellung von colloidnanopartikeln
DE69227974D1 (de) Mikrokapseln, welche anorganische Kolloiden enthalten, und Verfahren zur Herstellung
DE69033470D1 (de) Verfahren zur Herstellung von klebrigen Polymeren
DE69417510D1 (de) Verfahren zur Herstellung von feinteiligen, dichtpackenden und kugelförmigen Silberpartikeln
DE3884973D1 (de) Verfahren zur Herstellung von Avermectine-B und die verwendeten Kulturen.
DE69004317D1 (de) Verfahren zur direkten Herstellung von pigmenthaltigem Polyurethanpulver.
DE3860781D1 (de) Staubarmes spruehgetrocknetes emulsionspolymerisat und verfahren zu seiner herstellung und anwendung.
DE69126766D1 (de) Verfahren zur Herstellung von Polymerteilchen
DE69015391D1 (de) Verfahren zur Herstellung von Kunststoffteilchen.
DE59506720D1 (de) Verfahren zur Herstellung von siliciumoxidbeschichteten Feststoffteilchen
DE69602696D1 (de) Verfahren zur Herstellung von modifiziertem Polytetrafluorethylen-Feinpulver
DE69102805D1 (de) Verfahren zur Herstellung von nicht gesinterten Cristobalit-Teilchen.
DE59109153D1 (de) Verfahren zur Herstellung von Tetrafluorethylen-Polymerisat in wässriger Suspension
DE3689500D1 (de) Verfahren zur Herstellung von koagulierten kolloidalen Teilchen.
DE69012764D1 (de) Verfahren zur Herstellung von Titan und Titan-Legierungen mit einer feinen nadelförmigen Mikrostruktur.
DE69316702D1 (de) Verfahren zur Herstellung von Polymerpartikeln mit Unregelmässiger Form
DE69019768D1 (de) Verfahren zur kontinuierlichen Herstellung von feuchtem Polytetrafluoroethylen-Pulver.
DE69106162D1 (de) Verfahren zur Herstellung von nichthaftenden Gummipartikeln.
ATA67490A (de) Verfahren zur herstellung von kationischen lackbindemitteln und deren verwendung
DE59106107D1 (de) Verfahren und Vorrichtung zur Herstellung von Lackdrähten mit Schmelzharzen.
DE69501311D1 (de) Verfahren zur Herstellung von Polymerpartikeln
DE69330525D1 (de) Verfahren zur herstellung von kugelförmigen teilchen